---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-232894"
form_type: "8-K"
ticker: "TXMD"
cik: "0000025743"
company_name: "TherapeuticsMD, Inc."
filed_at: "2022-08-29T23:59:59+00:00"
generated_at: "2026-06-23T20:33:46.222545+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# TherapeuticsMD appoints Rubric Capital partner Justin Roberts to board of directors

## Summary
- Justin Roberts, Partner at Rubric Capital Management, appointed to fill newly created Board seat effective Aug. 23, 2022.
- Board size increased to nine directors; Roberts will stand for election at 2022 Annual Meeting.
- Rubric recently invested $15M in TherapeuticsMD via private placement of Series A Preferred and common stock (July 29, 2022).
- Roberts has elected not to receive any director compensation at this time.
- No other arrangements or material transactions between Roberts and Company beyond the Rubric investment.

## SEC filing metadata
- accession: 0001193125-22-232894
- form_type: 8-K
- ticker: TXMD
- cik: 0000025743
- company_name: TherapeuticsMD, Inc.
- filed_at: 2022-08-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/25743/000119312522232894/0001193125-22-232894-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/25743/000119312522232894/d742359d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-232894
- JSON: https://secwatch.observer/filing/0001193125-22-232894.json
- Plain text: https://secwatch.observer/filing/0001193125-22-232894.txt

## Key facts
- Executive change
  Justin Roberts was appointed as Director at TherapeuticsMD, Inc..
  - Action: appointed
  - Role: Director
  source text: On and effective as of August 23, 2022, the board of directors (the “Board”) of TherapeuticsMD, Inc., a Nevada corporation (the “Company”), appointed Mr. Justin Roberts as a director to fill a newly created vacancy on the Board as a result of the Board’s increase in the size of the Board by one director to a total of nine directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/25743/000119312522232894/0001193125-22-232894-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.